Literature DB >> 27230296

Aβ immunotherapy for Alzheimer's disease: where are we?

Jofre Güell-Bosch1, Laia Montoliu-Gaya1, Gisela Esquerda-Canals1, Sandra Villegas1.   

Abstract

Entities:  

Keywords:  Alzheimer's disease; amyloid-β; immunotherapy; new therapies; vaccine

Mesh：

Substances：

Year:  2016        PMID： 27230296     DOI： 10.2217/nmt-2016-0006

Source DB:  PubMed          Journal:  Neurodegener Dis Manag        ISSN： 1758-2024


× No keyword cloud information.
  3 in total

1.  Decreased Levels of Blood AMPKα1 but not AMPKα2 Isoform in Patients with Mild Cognitive Impairment and Alzheimer's Disease: A Pilot Study.

Authors:  Xin Wang; Helena R Zimmermann; Samuel N Lockhart; Suzanne Craft; Tao Ma
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

2.  Pharmacokinetic parameters and mechanism of action of an efficient anti-Aβ single chain antibody fragment.

Authors:  Gisela Esquerda-Canals; Joaquim Martí-Clúa; Sandra Villegas
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

3.  Isoform-specific dysregulation of AMP-activated protein kinase signaling in a non-human primate model of Alzheimer's disease.

Authors:  Xin Wang; Xueyan Zhou; Beth Uberseder; Jingyun Lee; Caitlin S Latimer; Cristina M Furdui; C Dirk Keene; Thomas J Montine; Thomas C Register; Suzanne Craft; Carol A Shively; Tao Ma
Journal:  Neurobiol Dis       Date:  2021-08-04       Impact factor: 7.046
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.